One-Year Safety Analysis of the COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133+ Bone Marrow Stem Cells to Placebo in Patients after Acute Myocardial Infarction and Left Ventricular Dysfunction
Open Access
- 27 February 2011
- journal article
- research article
- Published by Hindawi Limited in Bone Marrow Research
- Vol. 2011, 1-6
Abstract
Bone marrow stem cell therapy has emerged as a promising approach to improve healing of the infarcted myocardium. Despite initial excitement, recent clinical trials using non-homogenous stem cells preparations showed variable and mixed results. Selected CD133+ hematopoietic stem cells are candidate cells with high potential. Herein, we report the one-year safety analysis on the initial 20 patients enrolled in the COMPARE-AMI trial, the first double-blind randomized controlled trial comparing the safety, efficacy, and functional effect of intracoronary injection of selected CD133+ cells to placebo following acute myocardial infarction with persistent left ventricular dysfunction. At one year, there is no protocol-related complication to report such as death, myocardial infarction, stroke, or sustained ventricular arrhythmia. In addition, the left ventricular ejection fraction significantly improved at four months as compared to baseline and remained significantly higher at one year. These data indicate that in the setting of the COMPARE-AMI trial, the intracoronary injection of selected CD133+ stem cells is secure and feasible in patients with left ventricle dysfunction following acute myocardial infarction.Keywords
This publication has 18 references indexed in Scilit:
- Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic reviewEuropean Heart Journal, 2008
- Impact of Intracoronary Cell Therapy on Left Ventricular Function in the Setting of Acute Myocardial InfarctionJACC, 2007
- Adult Bone Marrow–Derived Cells for Cardiac RepairArchives of internal medicine (1960), 2007
- Cardiac Cell Therapy — Mixed Results from Mixed CellsNew England Journal of Medicine, 2006
- Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysisJournal of Cellular and Molecular Medicine, 2006
- Stem Cells for the Heart, Are We There Yet?Cardiology, 2003
- Identification of a novel class of human adherent CD34− stem cells that give rise to SCID-repopulating cellsBlood, 2003
- AC133 expression in human stem cellsLeukemia, 2001
- Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cellsJournal of Clinical Investigation, 2001
- CD34+AC133+Cells Isolated from Cord Blood are Highly Enriched in Long‐Term Culture‐Initiating Cells, NOD/SCID‐Repopulating Cells and Dendritic Cell ProgenitorsStem Cells, 1998